We previously showed that the messenger RNA and protein levels of the 11␤-hydroxysteroid dehydrogenase (11␤HSD) enzymes catalyzing glucocorticoid reduction (11␤HSD-1) and oxidation (11␤HSD-2) increased with advancing baboon gestation and concluded that the estrogen-regulated change in placental cortisol metabolism from reduction at midgestation to oxidation near term is not simply the result of a change in the relative concentrations of these two enzymes. Therefore, in the current study we determined whether 11␤HSD-1 and -2 are located in different regions of the baboon and human syncytiotrophoblast and whether there is a developmental change in their localization with advancing baboon gestation. Western blot analyses, immunofluorescence, and electron microscopic immunocytochemistry indicated that 11␤HSD-1 expression was abundant in microvillus membranes (MVM) juxta the maternal circulation, and their levels are significantly lower, but detectable, in more internal regions of the syncytiotrophoblast, including membranes contiguous with the basal membrane (BM m ) facing the fetal vasculature in both the human and baboon. In contrast, in both species 11␤HSD-2 expression was limited in the MVM and extensive throughout the remainder of the syncytiotrophoblast, including the BM m . In the baboon, the relative mean (ϮSE) concentrations (arbitrary densitometric units per g protein) of 11␤HSD-1 in the MVM were similar at mid (i.e. day 100; 38,859 Ϯ 3,484; n ϭ 3) and late (i.e. day 180; 43,561 Ϯ 1,784; n ϭ 3) gestation (term ϭ day 184) and exceeded (P Ͻ 0.01) respective values for 11␤HSD-2 by approximately 16-fold. In contrast, levels of 11␤HSD-1 in the BM m declined (P Ͻ 0.05) by approximately 50% between mid (7,099 Ϯ 758) and late (4,013 Ϯ 738) gestation, whereas levels of 11␤HSD-2 in this fraction increased. Thus, the ratio of 11␤HSD-2 to 11␤HSD-1 in the BM m at midgestation (1.22 Ϯ 0.10) was increased (P Ͻ 0.05) 2-fold in late gestation (2.66 Ϯ 0.05). Collectively, these findings indicate that the 11␤HSD-1 and -2 enzymes are localized to different membrane fractions of the baboon and human placental syncytiotrophoblast. Moreover, we propose that the developmental increase in the ratio of 11␤HSD-2 to 11␤HSD-1 in membranes facing fetal blood near term is consistent with and perhaps the subcellular mechanism responsible for the previously demonstrated switch in transplacental glucocorticoid metabolism from reduction at midgestation to oxidation late in gestation and appears to be responsible for the activation/maturation of the fetal pituitary-adrenocortical axis. (Endocrinology 142: 68 -80, 2001) W E HAVE PREVIOUSLY demonstrated that the estrogen-induced increase in transplacental oxidation of bioactive cortisol to bioinactive cortisone during the second half of baboon pregnancy (1) resulted in enhanced expression of ACTH by the fetal pituitary (2) and, consequently, maturation and ontogenesis of de novo production of cortisol by the fetal adrenal cortex (3, 4). The interconversion of cortisol and cortisone is catalyzed by two 11␤-hydroxysteroid dehydrogenase (11␤HSD-1 and -2) enzymes (5-7). Recently, we showed that the proteins for both 11␤HSD-1 and -2 were expressed in the baboon (8, 9) and human (9) placental syncytiotrophoblast. Moreover, our laboratories have shown that the messenger RNA (mRNA) and protein levels of 11␤HSD-1 and -2 in baboon syncytiotrophoblast progressively increased with advancing gestation (8) and that the activities of the 5Ј-flanking regions of both genes were enhanced by estrogen (10).
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It is well known that 11␤HSD-1 can function as a reductase, whereas 11␤HSD-2 only catalyzes the oxidation of cortisol to cortisone. Therefore, because the levels of both 11␤HSD enzymes were comparably increased in the syncytiotrophoblast with advancing gestation, we (8) concluded that the estrogen-induced change in the pattern of transplacental cortisol-cortisone metabolism from reduction at midgestation to oxidation near term is not simply the result of a change in the relative concentrations of these two enzymes. Rather, we propose that these two enzymes reside in different locations within the developing syncytiotrophoblast and that there is a developmental change in their localization that dictates the qualitative pattern of cortisol and cortisone crossing the syncytiotrophoblast into the fetus. Indeed, the syncytiotrophoblast is polarized, and such enzymes, including alkaline phosphatase and sodium-potassium adenosine triphosphatase, are localized specifically to the microvillus and basal membranes, respectively (11) . Therefore, the current study was designed to determine whether 11␤HSD-1 and -2 are located in different compartments of the baboon and human syncytiotrophoblast and whether there is a developmental change in their localization with advancing gestation. To examine these possibilities, we compared the levels of 11␤HSD-1 and -2 protein by Western blot in enriched fractions of the syncytiotrophoblast and their localization in the syncytiotrophoblast by immunofluorescence and electron microscopic (EM) immunocytochemistry in the baboon placenta obtained at mid-and late gestation and human placenta at term.
Materials and Methods

Tissue preparation
Placentas were obtained from baboons undergoing cesarean section on days 100 (i.e. mid; n ϭ 3) and 180 (i.e. late; n ϭ 3) of gestation (term ϭ day 184) and after elective cesarean section from women (n ϭ 2) with uncomplicated term pregnancies. Tissues were immediately rinsed several times in ice-cold 0.9% saline, and the decidua basalis and chorionic plate were dissected from placental villous tissue. Small portions of the placenta were then placed in 10% phosphate-buffered formalin (Sigma, St. Louis, MO) or Zamboni's fixative (12) for immunocytochemistry/EM or snap-frozen and stored in liquid nitrogen. Approximately 60 -70 g whole villous tissue were then used for the preparation of syncytiotrophoblast microvillus and basal membranes essentially as described by Kamath and Smith (11) . Briefly, villous tissue was minced, stirred with a magnetic stir bar for 60 min (4 C) in PBS (pH 7.4; Sigma), and filtered through nylon mesh (Sigma) to obtain filtrate and particulate fractions. The filtrate fraction was centrifuged at 800 ϫ g (to pellet debris), 10,000 ϫ g for 10 min (to pellet intracellular organelles), and then at 150,000 ϫ g for 25 min, after which the membrane pellet was homogenized in Trismannitol buffer to which 10 mm MgCl 2 was added. After incubation on ice for 10 min, the sample was centrifuged at 2,200 ϫ g for 12 min (to pellet endoplasmic reticulum) and then centrifuged at 150,000 ϫ g for 25 min to obtain the microvillus membranes (MVM), which were resuspended in Tris-sucrose buffer with gentle homogenization. The particulate fraction was washed four times with PBS and four times with 50 mm Tris. The sample was placed in an ice-ethanol bath and sonicated (15 g/100 ml 50 mm Tris) for 10 sec using a Biosonik IV sonicator (VWR Scientific, Baltimore, MD), and the fraction containing membranes contiguous with the basal membrane (BM m ) was filtered through six layers of gauze and collected. The sonicated tissue was washed, incubated for 10 min in 10 mm EDTA-Tris sucrose buffer at room temperature, and then sonicated again for 20 sec. The supernatant was then centrifuged at 10,000 ϫ g for 20 min and then at 150,000 ϫ g for 25 min to obtain the basal membrane (BM). All fractions collected were aliquoted and stored at Ϫ80 C until analyzed. In addition, a section of baboon whole villous placenta before membrane purification and the tissue remaining after mechanical stirring and after the first and second sonications were placed in Zamboni's fixative and prepared for examination by transmission EM essentially as described previously (12) .
Western blot analyses
Western blot analysis of 11␤HSD-1 and -2 in homogenates of whole villous placenta as well as in various membrane fractions, including the MVM, endoplasmic reticulum/cytosol, and the BM m , was performed essentially as described previously (8, 9) . Briefly, membrane fractions were solubilized in 1.0% Triton X-100 (Sigma), 250 mm sodium chloride (Sigma), 25 mm Tris-HCl (pH 7.5; Bio-Rad Laboratories, Inc. Richmond, CA), 5 mm EDTA (pH 8.0; Sigma), 1 mm phenylmethylsulfonylfluoride (Sigma), 2 g/ml aprotinin (Sigma), 2 g/ml pepstatin A (Sigma), and 10 g/ml leupeptin (Sigma) and incubated on ice for 20 min. Samples of whole villous tissue from baboon and human placentas were suspended in 1% cholic acid (Sigma), 0.1% SDS (Sigma), and 1 mm EDTA in PBS (pH 7.4) containing 0.1 mg/ml phenylmethylsulfonylfluoride, 10 g/ml aprotinin, and 0.1 mg/ml soybean inhibitor (Sigma) and homogenized on ice with a Polytron (Brinkmann Instruments, Inc., Westbury, NY). After determination of protein concentration by the bicinchoninic acid procedure (Sigma), 5 ϫ Laemmli buffer was added to a final concentration of 1 ϫ (13), and all samples were heated at 100 C for 5 min, cooled on ice for 2 min, and loaded (30 g protein/lane) onto discontinuous SDS-polyacrylamide minigels (12% for 11␤HSD-1; 10% for 11␤HSD-2) maintained in Bio-Rad Laboratories, Inc., Mini-Protean II electrophoresis chambers (Bio-Rad Laboratories, Inc.) containing chilled 0.025 m Tris, 0.192 m glycine (Bio-Rad Laboratories, Inc.), and 0.1% SDS buffer (pH 8.3). Samples were electrophoresed and wet transferred to Immobilon P (Millipore Corp., Bedford, MA) with a Mini Trans Blot transfer unit. The membrane was then blocked after incubation with constant agitation for 1 h at 37 C in 3% BSA in 50 mm Tris, pH 7.5, containing 150 mm NaCl and 0.05% Tween-20 (Bio-Rad Laboratories, Inc.). Samples were incubated (1 h) at room temperature with polyclonal antibodies to 11␤HSD-1 and -2, which were prepared (Cocalico Biologicals, Reamstown, PA) from rabbits injected with multiple antigenic peptides composed of an eight-branched lysine core matrix to which amino acids 22-36 of human 11␤HSD-1 and 332-345 of human 11␤HSD-2 were coupled as described previously (9) . Both antibodies were partially purified using a Protein A Plus column (Pierce Chemical Co., Rockford, IL) and dialyzed against PBS. The specificity and applicability of these antibodies for analysis of 11␤HSD-1 and -2 in baboon and human placenta were described previously (9) . Primary antibodies were diluted to 10 g/ml in buffer I [50 mm Tris (pH 7.5), 150 mm NaCl, 0.05% Tween-20, and 0.05% IGEPAL CA-630] containing 1.5% BSA. Membranes were washed and incubated at room temperature for 1 h with donkey antirabbit IgG horseradish peroxidase-conjugated second antibody (Amersham Pharmacia Biotech, Arlington Heights, IL) at the dilutions recommended by the manufacturer in buffer I containing 1.5% BSA. After washing, equal amounts of enhanced chemiluminescent reagent (ECL, Amersham Pharmacia Biotech) were applied to membranes for 1 min. Membranes were then wrapped in plastic, placed in x-ray film cassettes containing Fugi Medical x-ray film (Fugi Medical Systems, Stamford, CT), and exposed in a dark room for 15-180 sec. Preliminary studies confirmed that the second antibody contributed no nonspecific bands at the concentrations employed. To compare the levels of 11␤HSD-1 and -2 in whole villous homogenate, the MVM or the BM m between mid-and late gestation, Western blots were developed in the same film cassette for both 11␤HSD-1 and -2. After film development, samples were quantified by one-dimensional densitometry using an Image 1 analysis system (Universal Imaging Corp., Reamstown, PA), and results were expressed as arbitrary densitometric units per g protein, per mg tissue, or per placenta (8) .
Immunofluorescence
Sections (4 m) of formalin-fixed, paraffin-embedded baboon placenta were mounted onto SuperFrost Plus microscope slides (Fisher Scientific, Philadelphia, PA), and endogenous peroxidase was blocked with 0.4% hydrogen peroxide in methanol. Slides were placed in 10 mm sodium citrate buffer (pH 6.0; Sigma) and microwaved for 15 min. After cooling (30 min), sections were washed in PBS, blocked (30 min) in 5% normal goat serum (NGS; Vector Laboratories, Inc., Burlingame, CA), and then incubated overnight at 4 C with primary antibodies to 11␤HSD-1 and -2 diluted 1:2000 in 5% NGS. Sections were washed and incubated for 2 h at room temperature with biotinylated antirabbit IgG (Zymed Laboratories, Inc., South San Francisco, CA) diluted 1:500 in 5% NGS. Biotin was detected after treatment for 30 min in the dark with streptavidin conjugated with a Cy3 fluorotag (Zymed Laboratories, Inc.) diluted 1:50 in 5% NGS. Slides were rinsed in PBS, and autofluorescence was quenched by incubation (10 min) in the dark with Sudan Black (Sigma; 1% in 70% methanol). Sections were then rinsed in PBS, and coverslips were mounted using Vectashield mounting medium for fluorescence (Fisher Scientific) and secured using rubber cement. Slides were stored at 4 C in the dark until being photographed with Elite Chrome 400-color film (Eastman Kodak Co., Rochester, NY) using a Nikon FX-35 WA camera and Nikon MICROPHOT-FX microscope and rhodamine filter (Nikon, Melville, NY).
EM immunocytochemistry
EM immunocytochemistry was also used to confirm the intracellular localization of 11␤HSD-1 and -2 within the baboon syncytiotrophoblast at mid-and late gestation using primary antibodies to 11␤HSD-1 and -2 that were partially purified by ammonium sulfate precipitation. Sections of placental villous tissue were fixed overnight in Zamboni's solution and embedded in capsules containing LR White Resin (Fisher Scientific). Ultrathin sections were collected onto 200-mesh nickel grids and after blocking were incubated overnight (4 C) with or without primary antibodies to 11␤HSD-1 or -2. After several washes in Tris-buffered saline, sections were incubated at room temperature for 60 min with goat antirabbit secondary antibody-coated colloidal gold (18 nm), washed, counterstained with 2% aqueous uranyl acetate, and examined by transmission EM. Figure 1A illustrates a representative EM photomicrograph of the intact near-term baboon placental syncytiotrophoblast and its component nuclei and cellular organelles, a MVM facing the maternal side, and a BM facing the fetal vasculature. As shown in Fig. 1B , the MVM was totally removed by mechanical agitation in PBS, and as a consequence a portion of the cytosolic contents was extruded along with the MVM. However, the membranes contiguous with the BM (i.e. not contiguous with the MVM) and those cytosolic organelles of the syncytiotrophoblast not lost after mechanical agitation remained intact. Based on alkaline phosphatase activity, the MVM obtained by mechanical agitation was enriched at both mid-and late gestation approximately 16-to 20-fold by high speed centrifugation in mannitol and MgCl 2 (Table 1) . Because the fraction of the filtrate obtained by centrifugation at 10,000 ϫ g was also enriched for alkaline phosphatase activity by approximately 3-fold, it appears that the 10,000 ϫ g fraction also contained some MVM.
Results
Isolation of syncytiotrophoblast membrane fractions
As illustrated in Fig. 1C , the contents of the syncytiotrophoblast, including BM m , were released by sonication. However, the BM remained intact and was only released after a second sonication (data not shown). Alkaline phosphatase activity was minimal in BM m and BM (Table 1 ). The specific activity of alkaline phosphatase in whole villous homogenate and MVM was approximately 3-fold greater at late gestation than at midgestation ( Table 1 ). As shown in Table 2 , the concentration of soluble protein in whole villous placental homogenate was approximately 40% greater (P Ͻ 0.05) near term than at midgestation. Of the three trophoblast fractions examined, protein concentrations were greatest in BM m . However, protein concentrations in MVM, but not the BM m or 10,000 ϫ g fraction, appeared to be 2-to 3-fold greater (P ϭ 0.08) near term than at midgestation.
Western blot analysis of 11␤HSD-1 and -2
Figure 2 depicts representative Western blots for 11␤HSD-1 and -2 expression in homogenate of whole villous placenta and in MVM, the cytosolic contents released after mechanical agitation of the syncytiotrophoblast (i.e. the 10,000 ϫ g fraction), as well as the BM m released by sonication of the syncytiotrophoblast of baboon placenta obtained at mid-and late gestation and the human placenta collected at term. As previously demonstrated, in baboon and human placental syncytiotrophoblast (9), 11␤HSD-1 was expressed as a 32-kDa protein, and 11␤HSD-2 was expressed as a doublet of approximately 40 and 42 kDa. Specificity was confirmed by demonstration of the absence of the 32-kDa 11␤HSD-1 and 40-to 42-kDa 11␤HSD-2 signals using antibodies preabsorbed with an excess of the respective immunizing peptide (Fig. 2D) . In both the human and the baboon, 11␤HSD-1 expression was most extensive in the MVM, relatively lower in the 10,000 ϫ g fraction, and lower, but still FIG. 1. A, Transmission electron micrograph (original magnification, ϫ12,000) of the baboon placental syncytiotrophoblast obtained near term (i.e. day 180 of gestation; term ϭ day 184) and its component MVM, cellular organelles and BM juxta the fetal vasculature/inner villous core (IVC). B, Syncytiotrophoblast after mechanical agitation/ magnetic stirring for 60 min in PBS showing complete removal of the MVM and portions of the associated cellular contents. MVM and cellular contents released in PBS were filtered through nylon mesh, volume and osmolarity were adjusted by addition of Tris-mannitol and MgCl 2 , and then the MVM and cellular contents were subjected to differential centrifugation to isolate MVM from cytosolic components (10,000 ϫ g fraction). C, IVC remaining after sonication of the particulate fraction to release membranes contiguous with the BM of the syncytiotrophoblast.
detectable, in the BM m . Moreover, in the baboon, although the level of 11␤HSD-1 in the MVM was similar or slightly greater at term than at midgestation, 11␤HSD-1 expression in the BM m decreased with advancing gestation (Fig. 2) . In contrast to these observations, in both the human and the baboon, 11␤HSD-2 was expressed in low abundance in the MVM and was present in relatively high levels in both the 10,000 ϫ g fraction and the BM m . Moreover, in the baboon, levels of 11␤HSD-2 in the 10,000 ϫ g fraction and the BM m were similar at both mid-and late gestation. Based on location in the gel, it would appear that sonication of the BM m modified the 11␤HSD-2 protein. Thus, the mobility of 11␤HSD-2 in the 10,000 ϫ g fraction was comparably reduced after sonication (data not shown).
Immunofluorescence and EM of 11␤HSD-1 and -2
As shown in Fig. 3, 11␤HSD-1 was detected by immunofluorescence in the MVM and contiguous regions of the syncytiotrophoblast and occasionally in fetal vascular cells, but not in syncytiotrophoblast nuclei, at both mid (Fig. 3A) and late (Fig. 3B) gestation. Although 11␤HSD-1 was also detected in regions of the syncytiotrophoblast contiguous with and/or in proximity to the BM at midgestation (Fig. 3A) , expression of 11␤HSD-1 in this region of the syncytiotrophoblast juxta the inner villous core was considerably reduced in late gestation (Fig. 3B) . Similar results were observed using EM immunocytochemistry (Fig. 4) . Thus, gold particles reflective of 11␤HSD-1 expression were detected in the MVM and contiguous regions of the syncytiotrophoblast at both mid (Fig. 4A) and late (Fig. 4B) gestation. However, whereas gold particles reflective of 11␤HSD-1 were noted in the BM region of the syncytiotrophoblast at midgestation (Fig. 4A) , gold particles associated with 11␤HSD-1 became less abundant in regions close to fetal blood (i.e. inner villous core) in late gestation (Fig. 4B) . The specificity of these immunocytochemistry studies was confirmed by the absence of fluorescence and gold particles in sections of mid (Figs. 3E and 4C, respectively) and late (not shown) gestation baboon placenta incubated without primary antibody to 11␤HSD-1 and by the paucity of grains over nontissue areas in sections incubated with primary antibody (Fig. 4, A and B) .
In contrast to 11␤HSD-1, at both mid (Fig. 3C) and late ( Fig.  3D ) gestation, 11␤HSD-2 was detected by immunofluorescence throughout the syncytiotrophoblast, including regions close to the inner villous core, but was not expressed in the MVM. The protein for 11␤HSD-2 was also detected in and/or associated with the syncytiotrophoblast nuclei and was occasionally detected in vascular cells in the inner villous core. Consistent with these immunofluorescence data, EM immunocytochemistry showed that gold particles reflective of 11␤HSD-2 expression were uniformly distributed at mid (Fig. 5A) and late (Fig. 5B ) gestation throughout the syncytiotrophoblast, including regions contiguous with the BM (i.e. BM m ) as well as the BM itself, but were much less abundant in the MVM. Grains reflective of 11␤HSD-2 expression were also observed over syncytiotrophoblast nuclei and appeared to be associated mostly with the heterochromatin (not shown). Specificity was confirmed by the absence of fluorescence and gold particles in sections of mid (Figs. 3E and 5C, respectively) and late (not shown) gestation incubated without primary antibody to 11␤HSD-2 and by the paucity of grains over nontissue areas in sections incubated with primary antibody (Fig. 5C ).
Concentrations and ratios of 11␤HSD-1 and -2
As previously demonstrated (14) , the total capacity of the baboon placenta to oxidize cortisol to cortisone (i.e. NAD ϩ -dependent 11␤HSD-2 enzyme activity per placenta) was 3-fold greater near term than at midgestation (Fig. 6B) . However, because the volume fraction of the chorionic villi occupied by capillaries and extratrophoblastic components increases with advancing gestation, whereas the volume fraction of trophoblast remains relatively constant, and 11␤HSD is only expressed in the syncytiotrophoblast (8, 9) , the specific activity (e.g. per g protein) of 11␤HSD-2 was similar at mid-and late gestation (Fig. 6A) . Consistent with these observations, the results of the current study show that although the concentration of 11␤HSD-2 protein (arbitrary densitometric units) per g whole villous protein (Fig. 6C) or per mg tissue (not shown) was similar at mid (58,147 Ϯ 1,738) and late (48,023 Ϯ 3,769) gestation, total placental expression of 11␤HSD-2 protein (i.e. the product of 11␤HSD-2 and placental weight; units ϫ 10 Ϫ9 /placenta) was 3-fold greater (P ϭ 0.05) on day 180 (29.9 Ϯ 6.1) than on day 100 (11.3 Ϯ 2.8; Fig.  6D ). Similar observations were noted for 11␤HSD-1 protein Fractions of microvillus membrane (MVM), cytosol (10,000 ϫ g), endoplasmic reticulum contiguous with the basal membrane (BM m ), and basal membrane (BM) were isolated as described in Fig 1. Alkaline phosphatase activity (mean Ϯ SE) was determined spectrophotometrically.
a Greater (P Ͻ 0.05, by t test) than respective value at midgestation. Fractions of microvillus membrane (MVM), cytosol (10,000 ϫ g), and endoplasmic reticulum contiguous with the basal membrane (BM m ) isolated as described in Fig 1. a Greater (P Ͻ 0.05, by t test) than respective value at midgestation. concentrations (Fig. 6E ) and levels per placenta (Fig. 6F) . Thus, in whole villous baboon placenta, as previously shown for 11␤HSD-1 and -2 mRNA and protein levels in syncytiotrophoblast, the expression of both proteins increases with advancing gestation apparently at comparable rates, as indicated by the similarity in the ratio of 11␤HSD-2 to 11␤HSD-1 in whole villous homogenate at mid (2.0 Ϯ 0.2) and late (1.9 Ϯ 0.2) gestation (Fig. 6G) . Therefore, the similar increases in 11␤HSD-1 and -2 in whole villous placenta cannot account for the transplacental switch in conversion of bioactive cortisol to bioinactive cortisone between mid-and late gestation. As shown in Fig. 7 , the mean (Ϯse) concentrations (arbitrary densitometric units per g protein) of 11␤HSD-1 protein in the MVM were similar at mid (38,859 Ϯ 3,484) and late (43,561 Ϯ 1,784) gestation and greatly exceeded (P Ͻ 0.01) respective values for 11␤HSD-2 by approximately 16-fold (Fig. 7A) . When values were corrected for the total amount of protein associated with the MVM and expressed as total 11␤HSD-1 in the MVM (arbitrary densitometric units ϫ 10 Ϫ6 /placenta; Fig. 7B ), 11␤HSD-1 in the MVM was approximately 6-fold greater (P ϭ 0.07) in late gestation (101 Ϯ 32) than at midgestation (17 Ϯ 10). Again, however, the ratio of 11␤HSD-2 to 11␤HSD-1 in the MVM (Fig. 7C ) was similar at mid (0.06 Ϯ 0.04) and late (0.06 Ϯ 0.01) gestation, and therefore, levels of these enzymes in the MVM also cannot explain the switch in transplacental cortisol-cortisone metabolism with advancing gestation.
In contrast to the MVM, the concentration (units per g protein) of 11␤HSD-1 protein in the BM m , declined (P Ͻ 0.05) by approximately 50% between mid (7,099 Ϯ 759) and late (4,013 Ϯ 738; Fig. 8A ) gestation, and thus the total amount (units ϫ 10
Ϫ6
/placenta) of 11␤HSD-1 in the BM m did not change with advancing gestation (Fig. 8B) . However, the concentration (units per g protein) of 11␤HSD-2 in the BM m increased (Fig. 8A) , although not significantly, between mid (8,506 Ϯ 850) and late (10,624 Ϯ 3,194) gestation, and thus the total amount of 11␤HSD-2 in the BM m (units ϫ 10
/pla-
Comparison of mean (ϮSE) specific (units per g protein) and total (units per placenta) concentrations of 11␤-HSD-1 and -2 in extracts of whole villous baboon placenta on days 100 (n ϭ 3) and 180 (n ϭ 3) of gestation with specific and total 11␤-HSD-2 enzyme activity previously determined (14) on days 100 and 165 of gestation. The levels of 11␤-HSD-2 enzyme activity and of 11␤-HSD-1 and -2 per placenta were calculated as the product of 11␤-HSD per mg whole villous tissue and placental wet weight. The value at term exceeds (by t test) that at midgestation (*, P Ͻ 0.05; †, P ϭ 0.06).
centa) was approximately 2-fold greater at term (835 Ϯ 322) than at midgestation (383 Ϯ 97; Fig. 8B ). Because of these changes, the ratio of 11␤HSD-2 to 11␤HSD-1 in the BM m of FIG. 8. Mean (ϮSE) specific concentrations (A; units per g protein) and total amount (B; units per placenta) of 11␤-HSD-1 and -2 proteins determined by Western blot in the BM m of baboon syncytiotrophoblast prepared from placentas of mid (n ϭ 3; day 100) and late (n ϭ 3; day 180) gestation. Values with different letter superscripts differ from each other at P Ͻ 0.05 (by Student's t tests). C, Ratio (mean Ϯ SE) of the concentrations of 11␤-HSD-2 and 11␤-HSD-1 in membranes contiguous with the BM m at midgestation and late gestation (data from A). *, The value in late gestation differs from that at midgestation (P Ͻ 0.05, by t test for independent observations).
FIG. 7.
Mean (ϮSE) specific concentrations (A; units per g protein) and total amount (B; units per placenta) of 11␤-HSD-1 and -2 proteins determined by Western blot in the MVM of baboon syncytiotrophoblast prepared from placentas of mid (n ϭ 3; day 100) and late (n ϭ 3; day 180) gestation. C, Ratio (mean Ϯ SE) of the concentrations of 11␤-HSD-2 and 11␤-HSD-1 in MVM at midgestation and late gestation (data from A). *, The value for 11␤-HSD-1 exceeds that for 11␤-HSD-2 (P Ͻ 0.05, by t test).
the syncytiotrophoblast at midgestation (1.22 Ϯ 0.10) was increased (P Ͻ 0.05) by approximately 2-fold in late gestation (2.66 Ϯ 0.05; Fig. 8C ); these changes may explain the increased transplacental conversion of cortisol to cortisone near term.
Discussion
The results of the current study are the first to demonstrate that the 11␤HSD-1 and -2 enzymes are localized to different membrane fractions of the syncytiotrophoblast in both baboon and human placenta. Based on Western blot analyses of isolated membrane fractions as well as immunofluorescence and EM immunogold studies using highly specific antibodies, our findings indicate that the concentration of 11␤HSD-1 in the MVM juxta the maternal blood was extensive and greater than that in membranes more internal to the syncytiotrophoblast at both mid-and late gestation. Consequently, there was a gradient of 11␤HSD-1 expression across the syncytiotrophoblast, with expression being greatest on the maternal-facing surface. However, because the proportion of the syncytiotrophoblast comprised of MVM (e.g. protein associated with the MVM) was lower than that of membranes more internal, a significant amount of 11␤HSD-1 was present in membranes close to the fetal blood, particularly at midgestation, and therefore, any changes in enzyme content in the BM m would potentially have a significant impact on transplacental cortisol-cortisone interconversion. In contrast to 11␤HSD-1, 11␤HSD-2 expression in the MVM was minimal; rather, this enzyme was detected throughout the remainder of the syncytiotrophoblast, including cytosolic organelles and membranes contiguous with the BM facing the fetal blood compartment. Most significantly, our studies also are the first to demonstrate that the concentrations and absolute amounts of these two enzymes within the membranes contiguous with the BM were significantly different near term from those at midgestation. Thus, in the BM m the concentration of 11␤HSD-1 protein declined, whereas that of 11␤HSD-2 increased between mid-and late gestation, resulting in a 2-fold increase in the total amount of 11␤HSD-2 associated with this particular fraction of the syncytiotrophoblast by late gestation. As a consequence, there was a 2-fold increase in the ratio of 11␤HSD-2 to 11␤HSD-1 in the fraction of membranes juxta fetal blood. Moreover, this developmental change in the ratio of the reductive and oxidative 11␤HSD enzymes appears to be specific to the BM m and was not observed in the MVM, whole villous homogenate, or enriched fractions of baboon placental syncytiotrophoblast (8, 9) . Because 11␤HSD-2 functions exclusively as an oxidase and 11␤HSD-1 as a reductase, the last enzyme at the fetal: placental interface to which maternal corticosteroids crossing the placenta to the fetus would primarily be exposed in late gestation would be the 11␤HSD-2 catalyzing the conversion of cortisol to cortisone. Therefore, we suggest that the differential localization of the 11␤HSD enzymes in the syncytiotrophoblast and the developmental change in the ratio of 11␤HSD-2 to 11␤HSD-1 in membranes facing fetal blood provide the molecular architectural basis for the developmental switch in transplacental cortisol-cortisone metabolism that we previously demonstrated by in vivo isotope dilution procedures (15) . Thus, because of the decrease in 11␤HSD-1 and the increase in 11␤HSD-2 concentration in the BM m in late gestation, there would be an increase in transplacental conversion of bioactive cortisol to cortisone, as illustrated in Fig. 9 . Consequently, the secretion of cortisol into the baboon fetus that predominates during early to midgestation, presumably due to the relatively high levels of 11␤HSD-1 throughout the syncytiotrophoblast including the BM m , would decline near term, resulting in disinhibition of the fetal pituitary-adrenocortical axis, release of pituitary ACTH (2) , and activation/maturation of the fetal adrenal with de novo cortisol output (3) .
It is also well established that with advancing gestation there is a marked decrease in the mean villous diameter and a thinning of the villi overall, structural changes that decrease the effective diffusion distance across the villous membrane (16) . Because cortisone is a potent inhibitor of 11␤HSD-2 enzyme activity (14) , this developmental change in the structure of the villi may also be important physiologically, because the diffusion of cortisone to the fetus would presumably be enhanced (e.g. shorter distance), and 11␤HSD-2-catalyzed oxidation of cortisol to cortisone would be facilitated. Therefore, we propose that the spatial separation of the 11␤HSD-1 and -2 enzymes, the developmental change in their relative ratio within the syncytiotrophoblast membranes, and morphological changes in the syncytiotrophoblast are physiologically important to the maturation of the primate fetus.
In previous studies in the baboon we also demonstrated that the late gestational switch in placental glucocorticoid metabolism from reduction to oxidation was regulated by estrogen (1) . Thus, we speculate that the developmental change in the ratio of the 11␤HSD enzymes in specific membrane components of the placental syncytiotrophoblast of baboons in the present study is regulated by estrogen. Substantiation of this process would further indicate the integrative role that estrogen has in regulating key aspects of placental differentiation that have a major impact on fetal maturation.
Consistent with our previous studies (8, 9) demonstrating that the expression of 11␤HSD-1 and -2 in baboon syncytiotrophoblast increased with advancing gestation, the total amount of 11␤HSD-2 in whole villous placenta and in specific membrane components of the syncytiotrophoblast (i.e. BM m ) determined in this study were higher near term than at midgestation. Similarly, there was a 6-fold increase in the amount of 11␤HSD-1 associated with the MVM, presumably due to an increase in the quantity of MVM between mid-and late gestation, reflected in the current study as a 3-fold increase in the specific activity of the MVM-specific marker alkaline phosphatase.
The EM immunocytochemistry and immunofluorescence results of the current study suggest that 11␤HSD-2, but not 11␤HSD-1, was present in and/or associated with the nuclear envelope of syncytiotrophoblast nuclei. Consistent with these observations, there was abundant 11␤HSD-2 enzyme activity in 25,000 ϫ g fractions of human (17) and baboon (18) term placenta, indicating localization at sites in addition to the endoplasmic reticulum. Using confocal laser microscopy, Shimojo et al. (19) have shown that approximately 40% of total 11␤HSD-2 immunostaining in renal collecting ducts and colonic epithelial cells is nuclear in origin, confirming previous studies (20, 21) demonstrating nuclear renal 11␤HSD activity. However, these researchers as well as others (22) failed to detect 11␤HSD protein in nuclei of human term placenta and thus presumed that 11␤HSD-2 was localized almost exclusively to endoplasmic reticulum (23, 24) .
Mechanisms by which proteins uniquely move and insert into specific membranes of polarized cells, including the syncytiotrophoblast (25), are extremely complex and not completely understood (26) . Neither 11␤HSD-1 nor 11␤HSD-2 has sorting signals in their ectodomains that would target them to specific membrane fractions. Studies have shown that 11␤HSD-1 is glycosylated (27, 28) and 11␤HSD-2 contains a potential glycosylation site (9) and was indeed detected as a doublet in human and baboon syncytiotrophoblast in the present study as well as our previous study (9) . However, despite the fact that glycosylation could affect cellular localization, it has also been shown that modification of such posttranslational processing of other proteins does not necessarily alter sorting (26) . Thus, the factors acting to target 11␤HSD-1 to the MVM and 11␤HSD-2 to other syncytiotrophoblast components remain to be elucidated. Recent studies (29) have demonstrated that the ezrinradixin-moesin family of proteins plays structural and regulatory roles in the assembly and stabilization of specialized plasma membrane domains and that ezrin and related molecules are concentrated in surface projections such as microvilli to link microfilaments to the membrane. Interestingly, ezrin is abundantly expressed in the human placenta and is localized specifically to the microvilli (30) . Whether ezrin or other relevant regulatory factors bind and/or complex with the 11␤HSD-1 and/or -2 proteins to provide a mechanism by which the 11␤HSD enzymes are targeted to distinct regions of the syncytiotrophoblast remains to be elucidated.
Recently, it has been shown in the rat placenta that 11␤HSD-1 and -2 were localized primarily to the labyrinth and basal zones, respectively (31) . Moreover, the ratio of the mRNAs and activities of 11␤HSD-2 and 11␤HSD-1 changed significantly in late rat gestation (7, 31) . Thus, the spatial separation of 11␤HSD-1 and -2 in the syncytiotrophoblast of baboon and human placenta as shown in the present study also appears to occur in the rodent placenta.
In summary, the current study shows that the 11␤HSD-1 and -2 enzymes were localized to different fractions of baboon and human syncytiotrophoblast. 11␤HSD-1 was localized extensively to the MVM, whereas 11␤HSD-2 was located throughout the remainder of the syncytiotrophoblast, including the BM m facing the fetal blood compartment. Moreover, there was a developmental increase in the ratio of 11␤HSD-2 to 11␤HSD-1 in the syncytiotrophoblast membranes juxta the fetal blood compartment, which we propose is consistent with and perhaps the subcellular mechanism responsible for the previously demonstrated switch in transplacental glucocorticoid metabolism from reduction at midgestation to oxidation late in gestation and which appears to be responsible for the activation/maturation of the fetal pituitary-adrenocortical axis.
